• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

The N-terminal domain of human urokinase receptor contains two distinct regions critical for ligand recognition.

作者信息

Pöllänen J J

机构信息

National Biotechnology Programmes, Center for Molecular Cell Biology, Copenhagen, Denmark.

出版信息

Blood. 1993 Nov 1;82(9):2719-29.

PMID:8219225
Abstract

The high-affinity receptor that binds human urokinase-type plasminogen activator (hu-PAR) is a glycosyl-phosphatidylinositol (GPI)-anchored cell-surface glycoprotein that belongs to the Ly-6 superfamily of T-cell-activating receptors. Binding of urokinase (u-PA) to u-PAR is species-specific, since neither murine (mu-PAR) nor hu-PAR binds u-PA from the other species. I designed and analyzed a series of exchanges between hu-PAR and mu-PAR in the N-terminal first domain to which ligand-binding function had been independently mapped. Introduction of as few as 13 murine residues (six of 13 variables) into the N-terminal region of hu-PAR abrogated binding to recombinant human pro-u-PA, whereas the opposite chimera, a mu-PAR carrying six of 13 human residues, was positive for binding. Within this region, the mu-PAR domain 1 could be minimally humanized to bind human pro-u-PA by a substitution of as few as four of the six nonconserved residues, thereby identifying the residues arginine-2, lysine-7, threonine-8, and glycine-10 as important in determining binding specificity. By alanine-scanning mutagenesis, a second recognition site within domain 1 was discovered between residues 47 and 53, a segment that is fully conserved between the human and the mouse receptors. Taken together, these results provide identification of two confined subregions within the N-terminal domain of hu-PAR critically involved in pro-u-PA recognition.

摘要

相似文献

1
The N-terminal domain of human urokinase receptor contains two distinct regions critical for ligand recognition.
Blood. 1993 Nov 1;82(9):2719-29.
2
Binding of human single chain urokinase to Chinese Hamster Ovary cells and cloning of hamster u-PAR.人单链尿激酶与中国仓鼠卵巢细胞的结合及仓鼠尿激酶型纤溶酶原激活物受体的克隆
Thromb Haemost. 1998 Jul;80(1):148-54.
3
Identification and characterization of the murine cell surface receptor for the urokinase-type plasminogen activator.尿激酶型纤溶酶原激活剂的小鼠细胞表面受体的鉴定与特性分析
Eur J Biochem. 1992 Apr 15;205(2):451-8. doi: 10.1111/j.1432-1033.1992.tb16799.x.
4
N-linked glycosylation of the ligand-binding domain of the human urokinase receptor contributes to the affinity for its ligand.人尿激酶受体配体结合域的N-连接糖基化作用有助于其对配体的亲和力。
J Biol Chem. 1993 May 25;268(15):11152-9.
5
Regulation of the urokinase-type plasminogen activator receptor on vascular smooth muscle cells is under the control of thrombin and other mitogens.血管平滑肌细胞上尿激酶型纤溶酶原激活物受体的调控受凝血酶和其他促细胞分裂剂的控制。
Arterioscler Thromb. 1992 Oct;12(10):1161-70. doi: 10.1161/01.atv.12.10.1161.
6
Characterization of the binding of urokinase-type plasminogen activator (u-PA) to plasminogen, to plasminogen-activator inhibitor-1 and to the u-PA receptor.尿激酶型纤溶酶原激活剂(u-PA)与纤溶酶原、纤溶酶原激活剂抑制剂-1及u-PA受体结合的特性
Eur J Biochem. 1994 Sep 1;224(2):567-74. doi: 10.1111/j.1432-1033.1994.00567.x.
7
Thrombin decreases the urokinase receptor and surface-localized fibrinolysis in cultured endothelial cells.凝血酶可降低培养的内皮细胞中的尿激酶受体及表面定位的纤维蛋白溶解作用。
Arterioscler Thromb Vasc Biol. 1995 Mar;15(3):410-9. doi: 10.1161/01.atv.15.3.410.
8
Cellular receptor for urokinase plasminogen activator. Carboxyl-terminal processing and membrane anchoring by glycosyl-phosphatidylinositol.
J Biol Chem. 1991 Jan 25;266(3):1926-33.
9
Bovine urokinase-type plasminogen activator and its receptor: cloning and induction by retinoic acid.牛尿激酶型纤溶酶原激活剂及其受体:克隆与视黄酸诱导
Gene. 1993 Mar 30;125(2):177-83. doi: 10.1016/0378-1119(93)90325-w.
10
Structural requirements for glycosyl-phosphatidylinositol-anchor attachment in the cellular receptor for urokinase plasminogen activator.尿激酶型纤溶酶原激活剂细胞受体中糖基磷脂酰肌醇锚定连接的结构要求。
Eur J Biochem. 1992 Sep 1;208(2):493-500. doi: 10.1111/j.1432-1033.1992.tb17213.x.

引用本文的文献

1
Binding of high molecular weight kininogen to human endothelial cells is mediated via a site within domains 2 and 3 of the urokinase receptor.高分子量激肽原与人内皮细胞的结合是通过尿激酶受体第2和第3结构域内的一个位点介导的。
J Clin Invest. 1997 Sep 15;100(6):1481-7. doi: 10.1172/JCI119669.
2
Epitope-mapped monoclonal antibodies as tools for functional and morphological analyses of the human urokinase receptor in tumor tissue.经表位映射的单克隆抗体作为肿瘤组织中人尿激酶受体功能和形态分析的工具。
Am J Pathol. 1997 Apr;150(4):1231-44.
3
High-affinity urokinase receptor antagonists identified with bacteriophage peptide display.
通过噬菌体肽展示技术鉴定出的高亲和力尿激酶受体拮抗剂。
Proc Natl Acad Sci U S A. 1994 Jul 19;91(15):7129-33. doi: 10.1073/pnas.91.15.7129.
4
Increase of a urokinase receptor-related low-molecular-weight molecule in colorectal adenocarcinomas.结直肠癌中尿激酶受体相关低分子量分子的增加。
Clin Exp Metastasis. 1995 Nov;13(6):492-8. doi: 10.1007/BF00118188.